Person profile
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Akero Therapeutics, Inc.
11 Jun 24
4
OptiNose, Inc.
7 Jun 24
4
EXELIXIS, INC.
4 Jun 24
144
Legend Biotech Corp
12 Dec 23
4
Akero Therapeutics, Inc.
27 Jun 23
4
Akero Therapeutics, Inc.
21 Jun 23
144
Akero Therapeutics, Inc.
16 Jun 23
4
Xilio Therapeutics, Inc.
13 Jun 23
4
OptiNose, Inc.
9 Jun 23
4
EXELIXIS, INC.
2 Jun 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jun 24 | AKRO Akero Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 23.02 | 26,000 | 598.52 k | 26,000 |
6 Jun 24 | OPTN OptiNose | Stock Option Common Stock | Grant | Acquire A | No | No | 1.04 | 75,000 | 78.00 k | 75,000 |
31 May 24 | EXEL Exelixis | Common Stock | Grant | Acquire A | No | No | 0 | 18,838 | 0.00 | 37,014 |
23 Jun 23 | AKRO Akero Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 50.83 | 15,000 | 762.45 k | 15,000 |
16 Jun 23 | AKRO Akero Therapeutics | Common Stock | Sell | Dispose S | No | No | 54.6742 | 26,000 | 1.42 mm | 0 |
16 Jun 23 | AKRO Akero Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 25.04 | 26,000 | 651.04 k | 26,000 |
16 Jun 23 | AKRO Akero Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 25.04 | 26,000 | 651.04 k | 0 |